| Factor Information | |
|---|---|
| Data ID | 2539 |
| Factor | left frontal beta power |
| Description | BSID=Bayley Scales of Infant Development |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | The purpose of this study was to investigate early markers of risk for neurobehavioral compromise in survivors with congenital heart disease (CHD). |
| p Value | 0.016 |
| Conclusion | In fetuses with HLHS, TGA and TOF, abnormal cerebrovascular resistance predicts decreased neonatal EEG left frontal beta power and lower 18-month cognitive development scores. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 607 |
| CHD Type | isolated CHD |
| CHD Subtype | HLHS/TGA/TOF |
| Reference | |
|---|---|
| PMID | 22351034 |
| Year | 2012 |
| Title | Fetal cerebrovascular resistance and neonatal EEG predict 18-month neurodevelopmental outcome in infants with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | fetus and infants | |
| Source | patients' data | |
| Region | New York, America | |
| Method | student's t test | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CPR<1 group (CPR=cerebral-to-placental resisitance ratio)(Treatment) | CPR>=1 group(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
